1. "Body Imaging Service"
Formats
  1. Journal Article (1718)
  2. Meeting Abstract (519)
  3. Review (163)
  4. Book Section (128)
  5. Conference Paper (43)
  6. Editorial (35)
  7. Guidelines (29)
  8. Miscellaneous (16)
  9. Correspondence (11)
  10. Book Whole (5)
  11. Research Letter (4)
Groups
  1. Body Imaging Service (2671)
  2. Radiology, Department of (2670)
  3. Department of Medicine (992)
  4. Solid Tumor Oncology Division (875)
  5. Surgery (752)
  6. Epidemiology and Biostatistics (734)

More Groups

People
  1. Lawrence Schwartz (306)
  2. Oguz Akin (264)
  3. Kinh Gian Do (256)
  4. Michelle Ginsberg (235)
  5. Marc Gollub (208)
  6. Hedvig Hricak (158)

More People

Years
  1. 2025 (69)
  2. 2024 (169)
  3. 2023 (220)
  4. 2022 (200)
  5. 2021 (189)
  6. 2020 (165)

More Years

Publications
  1. Journal of Clinical Oncology (322)
  2. American Journal of Roentgenology (147)
  3. Radiology (122)
  4. Abdominal Radiology (84)
  5. European Radiology (67)
  6. Clinical Cancer Research (65)

More Publications

Publishers
  1. Springer (359)
  2. American Society of Clinical Oncology (346)
  3. Elsevier Inc. (316)
  4. American Roentgen Ray Society (147)
  5. Radiological Society of North America, Inc. (141)
  6. Elsevier Science, Inc. (128)

More Publishers

Results (2671)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Radiomics for CT assessment of vascular contact in pancreatic adenocarcinoma
    Editorial

    Do, R. K. G.; Kambadakone, A.
    Radiology (2021)

    Fulltext@MSK | Save
  • Radiomics in surgical oncology: Applications and challenges
    Review

    Williams, T. L.; Saadat, L. V.; Gonen, M.; Wei, A.; Do, R. K. G.; Simpson, A. L.
    Computer Assisted Surgery (2021)

    Fulltext@MSK | Save
  • Assessing PD-L1 expression status using radiomic features from contrast-enhanced breast MRI in breast cancer patients: Initial results
    Journal Article

    Lo Gullo, R.; Wen, H.; Reiner, J. S.; Hoda, R.; Sevilimedu, V.; Martinez, D. F.; Thakur, S. B.; Jochelson, M. S.; Gibbs, P.; Pinker, K.
    Cancers (2021)

    Fulltext@MSK | Save
  • Skeletal muscle metastases in neuroblastoma: An ostensible "forme fruste" of stage MS disease
    Meeting Abstract

    Fong, C.; Kushner, B.; Di Giannatale, A.; Roberts, S.; Basu, E.; Price, A.; Cheung, N. K.; Modak, S.
    Pediatric Blood and Cancer (2021)

    Fulltext@MSK | Save
  • Long-term outcomes and characteristics of unresectable locally advanced thymic malignancies
    Meeting Abstract

    Sideris, A.; Li, X.; Oufkir, H.; Curry, M.; Tan, K. S.; Araujo-Filho, J.; Robinson, E.; Jones, D.; Ginsberg, M.; Rimner, A.; more...
    Journal of Thoracic Oncology (2021)

    Fulltext@MSK | Save
  • Association of a very high tumor mutational load with increased CD8+ and PD-1+ T-cell infiltration and improved clinical outcomes to PD-(L)1 blockade across different PD-L1 expression levels in non-small cell lung cancer
    Meeting Abstract

    Ricciuti, B.; Arbour, K. C.; Alessi, J. V. M.; Mahadevan, N.; Lindsay, J.; Sinha, R.; Vokes, N. I.; Recondo, G.; Lamberti, G.; Rizvi, H.; more...
    Journal of Clinical Oncology (2021)

    Fulltext@MSK | Save
  • Nivolumab plus cabozantinib in patients with non-clear cell renal cell carcinoma: Results of a phase 2 trial
    Meeting Abstract

    Lee, C. H.; Voss, M. H.; Carlo, M. I.; Chen, Y. B.; Reznik, E.; Knezevic, A.; Lefkowitz, R. A.; Shapnik, N.; Tassone, D.; Dadoun, C.; more...
    Journal of Clinical Oncology (2021)

    Fulltext@MSK | Save
  • Determination of clinical benefit among patients with radiological stable disease to immune checkpoint inhibitors
    Meeting Abstract

    Luo, J.; Wu, S.; Rizvi, H.; Zhang, Q.; Egger, J. V.; Osorio, J. C.; Schoenfeld, A. J.; Plodkowski, A. J.; Ginsberg, M. S.; Gupta, A. K.; more...
    Journal of Clinical Oncology (2021)

    Fulltext@MSK | Save
  • Response to immune checkpoint inhibition as monotherapy or in combination with chemotherapy in metastatic ROS1-rearranged lung cancers
    Meeting Abstract

    Choudhury, N. J.; Schneider, J. L.; Patil, T.; Zhu, V. W.; Goldman, D. A.; Yang, S. R.; Falcon, C.; Do, A.; Nie, Y.; Plodkowski, A. J.; more...
    Journal of Clinical Oncology (2021)

    Fulltext@MSK | Save
  • Early predictors of benefit to dual anti-PD1/HER2 inhibition: Biomarker analysis from phase 2 trial of pembrolizumab/trastuzumab in HER2-positive metastatic esophagogastric (mEG) cancer
    Meeting Abstract

    Maron, S. B.; Chatila, W. K.; Walch, H. S.; Ptashkin, R.; Sabwa, S.; Ling, L.; Nagy, R.; Simmons, M.; Do, R. K. G.; Paroder, V.; more...
    Journal of Clinical Oncology (2021)

    Fulltext@MSK | Save